| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Pathology [A. Y., K. O., T. K., H. S., Y. K.], Internal Medicine [K. O.], and Surgery [M. H.], Cancer Institute, 1-37-1 Kami-Ikebukuro, Toshima-ku, Tokyo, 170 Japan
In order to scrutinize the possible significance of (nonatypical) mucous cell hyperplasia of the pancreas to neoplasia, we analyzed these lesions in terms of c-Ki-ras activation, which is known to be very frequent in pancreatic carcinomas. A total of 16 such mucous cell hyperplasias were collected from 10 pancreases resected for chronic pancreatitis. Tiny tissue fragments were taken from hematoxylin-stained sections by microdissection, and DNA analysis was carried out by the polymerase chain reaction amplification and oligonucleotide hybridization methods. Activating mutations of c-Ki-ras oncogene at codon 12 were detected in 10 of the 16 lesions (62.5%), a high rate as seen in carcinomas. The results indicated a clonal origin of cells comprising the mucous cell hyperplasia suggesting a neoplastic and/or precancerous nature.
1 This work was supported in part by the Ministry of Education, Science and Culture and the Ministry of Health and Welfare.
2 To whom requests for reprints should be addressed.
Received 12/11/92. Accepted 1/20/93.
This article has been cited by other articles:
![]() |
P. Ghaneh, E. Costello, and J. P Neoptolemos Biology and management of pancreatic cancer Gut, August 1, 2007; 56(8): 1134 - 1152. [Full Text] [PDF] |
||||
![]() |
J Watari, A Tanaka, H Tanabe, R Sato, K Moriichi, A Zaky, K Okamoto, A Maemoto, M Fujiya, T Ashida, et al. K-ras mutations and cell kinetics in Helicobacter pylori associated gastric intestinal metaplasia: a comparison before and after eradication in patients with chronic gastritis and gastric cancer J. Clin. Pathol., August 1, 2007; 60(8): 921 - 926. [Abstract] [Full Text] [PDF] |
||||
![]() |
T M Gress Molecular diagnosis of pancreatobiliary malignancies in brush cytologies of biliary strictures Gut, December 1, 2004; 53(12): 1727 - 1729. [Full Text] [PDF] |
||||
![]() |
T. Furukawa, M. Sunamura, F. Motoi, S. Matsuno, and A. Horii Potential Tumor Suppressive Pathway Involving DUSP6/MKP-3 in Pancreatic Cancer Am. J. Pathol., June 1, 2003; 162(6): 1807 - 1815. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Klump, C.-J. Hsieh, S. Dette, K. Holzmann, R. Kiesslich, M. Jung, U. Sinn, M. Ortner, R. Porschen, and M. Gregor Promoter Methylation of INK4a/ARF As Detected in Bile-Significance for the Differential Diagnosis in Biliary Disease Clin. Cancer Res., May 1, 2003; 9(5): 1773 - 1778. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Postier, M. R. Lerner, S. A. Lightfoot, R. Vannarath, M. M. Lane, J. S. Hanas, and D. J. Brackett DNA Ploidy and Markovian Analysis of Neoplastic Progression in Experimental Pancreatic Cancer J. Histochem. Cytochem., March 1, 2003; 51(3): 303 - 309. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Komori, O. Ishikawa, H. Ohigashi, T. Yamada, Y. Sasaki, S. Imaoka, A. Nakaizumi, H. Uehara, S. Tanaka, Y. Mano, et al. Invasive Ductal Adenocarcinoma of the Remnant Pancreatic Body 9 Years after Resection of an Intraductal Papillary-Mucinous Carcinoma of the Pancreatic Head: a Case Report and Comparison of DNA Sequence in K-ras Gene Mutation Jpn. J. Clin. Oncol., April 1, 2002; 32(4): 146 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Hidaka, A Yanagisawa, M Seki, T Setoguchi, and Y Kato Genetic alterations and growth pattern in biliary duct carcinomas: loss of heterozygosity at chromosome 5q bears a close relation with polypoid growth Gut, May 1, 2001; 48(5): 656 - 659. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Aoki, A. Tsuchida, K. Kasuya, M. Endo, K. Kitamura, and Y. Koyanagi Is Preventive Resection of the Extrahepatic Bile Duct Necessary in Cases of Pancreaticobiliary Maljunction Without Dilatation of the Bile Duct? Jpn. J. Clin. Oncol., March 1, 2001; 31(3): 107 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ohigashi, O. Ishikawa, Y. Sasaki, T. Yamada, H. Furukawa, S. Imaoka, T. Kasugai, S. Ishiguro, K. Ueda, Y. Miyoshi, et al. K-ras Point Mutation in the Nerve Plexuses Around the Superior Mesenteric Artery in Resectable Adenocarcinoma of the Pancreatic Head: Distribution Pattern and Related Factors Arch Surg, December 1, 2000; 135(12): 1450 - 1455. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Hruban, M. Goggins, J. Parsons, and S. E. Kern Progression Model for Pancreatic Cancer Clin. Cancer Res., August 1, 2000; 6(8): 2969 - 2972. [Full Text] |
||||
![]() |
E. Heinmoller, W. Dietmaier, H. Zirngibl, P. Heinmoller, W. Scaringe, K.-W. Jauch, F. Hofstadter, and J. Ruschoff Molecular Analysis of Microdissected Tumors and Preneoplastic Intraductal Lesions in Pancreatic Carcinoma Am. J. Pathol., July 1, 2000; 157(1): 83 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Sorenson Detection of Mutated KRAS2 Sequences as Tumor Markers in Plasma/Serum of Patients with Gastrointestinal Cancer Clin. Cancer Res., June 1, 2000; 6(6): 2129 - 2137. [Abstract] [Full Text] |
||||
![]() |
R. H. Hruban, R. E. Wilentz, and S. E. Kern Genetic Progression in the Pancreatic Ducts Am. J. Pathol., June 1, 2000; 156(6): 1821 - 1825. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamano, H. Fujii, T. Takagaki, N. Kadowaki, H. Watanabe, and T. Shirai Genetic Progression and Divergence in Pancreatic Carcinoma Am. J. Pathol., June 1, 2000; 156(6): 2123 - 2133. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Wilentz, C. A. Iacobuzio-Donahue, P. Argani, D. M. McCarthy, J. L. Parsons, C. J. Yeo, S. E. Kern, and R. H. Hruban Loss of Expression of Dpc4 in Pancreatic Intraepithelial Neoplasia: Evidence That DPC4 Inactivation Occurs Late in Neoplastic Progression Cancer Res., April 1, 2000; 60(7): 2002 - 2006. [Abstract] [Full Text] |
||||
![]() |
J. Serth, M. A. Kuczyk, U. Paeslack, R. Lichtinghagen, and U. Jonas Quantitation of DNA Extracted after Micropreparation of Cells from Frozen and Formalin-Fixed Tissue Sections Am. J. Pathol., April 1, 2000; 156(4): 1189 - 1196. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Adell, A. Gómez-Cuadrado, A. Skoudy, O. S. Pettengill, D. S. Longnecker, and F. X. Real Role of the Basic Helix-Loop-Helix Transcription Factor p48 in the Differentiation Phenotype of Exocrine Pancreas Cancer Cells Cell Growth Differ., March 1, 2000; 11(3): 137 - 147. [Abstract] [Full Text] |
||||
![]() |
E. Hidaka, A. Yanagisawa, M. Seki, K. Takano, T. Setoguchi, and Y. Kato High Frequency of K-ras Mutations in Biliary Duct Carcinomas of Cases with a Long Common Channel in the Papilla of Vater Cancer Res., February 1, 2000; 60(3): 522 - 524. [Abstract] [Full Text] |
||||
![]() |
K Tateishi, M Tada, M Yamagata, H Isayama, Y Komatsu, T Kawabe, Y Shiratori, and M Omata High proportion of mutant K-ras gene in pancreatic juice of patients with pancreatic cystic lesions Gut, November 1, 1999; 45(5): 737 - 740. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ohnami, N. Matsumoto, M. Nakano, K. Aoki, K. Nagasaki, T. Sugimura, M. Terada, and T. Yoshida Identification of Genes Showing Differential Expression in Antisense K-ras-transduced Pancreatic Cancer Cells with Suppressed Tumorigenicity Cancer Res., November 1, 1999; 59(21): 5565 - 5571. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yamaguchi, H. Watanabe, S. Yrdiran, K. Ohtsubo, Y. Motoo, T. Okai, and N. Sawabu Detection of Mutations of p53 Tumor Suppressor Gene in Pancreatic Juice and Its Application to Diagnosis of Patients with Pancreatic Cancer: Comparison with K-ras Mutation Clin. Cancer Res., May 1, 1999; 5(5): 1147 - 1153. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. J. Sturm, E. A. J. Rauws, R. H. Hruban, E. Caspers, T. B. Ramsoekh, K. Huibregtse, L. A. Noorduyn, and G. J. A. Offerhaus Clinical Value of K-ras Codon 12 Analysis and Endobiliary Brush Cytology for the Diagnosis of Malignant Extrahepatic BileDuct Stenosis Clin. Cancer Res., March 1, 1999; 5(3): 629 - 635. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Castells, P. Puig, J. Mora, J. Boadas, L. Boix, E. Urgell, M. Sole, G. Capella, F. Lluis, L. Fernandez-Cruz, et al. K-ras Mutations in DNA Extracted From the Plasma of Patients With Pancreatic Carcinoma: Diagnostic Utility and Prognostic Significance J. Clin. Oncol., February 1, 1999; 17(2): 578 - 578. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mora, P. Puig, J. Boadas, E. Urgell, E. Montserrat, E. Lerma, F. Gonzalez-Sastre, F. Lluis, A. Farre, and G. Capella K-ras gene mutations in the diagnosis of fine-needle aspirates of pancreatic masses: prospective study using two techniques with different detection limits Clin. Chem., November 1, 1998; 44(11): 2243 - 2248. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Berndt, K. Haubold, F. Wenger, B. Brux, J. Muller, P. Bendzko, T. Hillebrand, E. Kottgen, and J. Zanow K-ras mutations in stools and tissue samples from patients with malignant and nonmalignant pancreatic diseases Clin. Chem., October 1, 1998; 44(10): 2103 - 2107. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Maule, G. Ramadori, H. Munke, R. M. Schmid, G. Adler, and D. Seidler Chronic Pancreatitis N. Engl. J. Med., November 2, 1995; 333(18): 1221 - 1222. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |